SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-202385
Filing Date
2021-06-29
Accepted
2021-06-28 20:56:03
Documents
1
Group Members
ATP III GP, LTD.SETH L. HARRISON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d188869dsc13da.htm SC 13D/A 65293
  Complete submission text file 0001193125-21-202385.txt   66964
Mailing Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169
Business Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169 212-468-5800
ATP Life Science Ventures, L.P. (Filed by) CIK: 0001593440 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91047 | Film No.: 211055281
SIC: 2834 Pharmaceutical Preparations